Also, funnily enough, in an actual capitalist environment you couldn't do this, because a competitor would immediately undercut you. However, the drugs market is heavily regulated, and Skhreli exploited the fact that it would take years and cost a lot of money for any putative competitor to get a generic version through FDA approvals.
It's more than that, the FDA grants advertising exclusivity, which is de jure weaker than patents (the patent office and the law regulates patent criteria, the FDA cannot) but is de facto just as effective, and is an IP lock on the product. (I would also call this "not really free market capitalism")
As noted, this was all legal and I agree that he was railroaded to jail for essentially completely unrelated wrongdoings, but there's no universe where he's not a scumbag.
Focus on developing products to treat rare diseases characterized by severe unmet medical needs.
I also see several preclinical programs and product candidates. You must have missed those. Odd case, very strange.